371 related articles for article (PubMed ID: 29889694)
1. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren's syndrome.
Thorlacius GE; Wahren-Herlenius M; Rönnblom L
Curr Opin Rheumatol; 2018 Sep; 30(5):471-481. PubMed ID: 29889694
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.
Wang Y; Chen S; Chen J; Xie X; Gao S; Zhang C; Zhou S; Wang J; Mai R; Lin Q; Lin J; Matucci-Cerinic M; Zhang G; Furst DE
Ann Rheum Dis; 2020 Feb; 79(2):268-275. PubMed ID: 31848144
[TBL] [Abstract][Full Text] [Related]
3. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
4. Genetics of systemic lupus erythematosus and Sjögren's syndrome: an update.
Teruel M; Alarcón-Riquelme ME
Curr Opin Rheumatol; 2016 Sep; 28(5):506-14. PubMed ID: 27227345
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
[TBL] [Abstract][Full Text] [Related]
6. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
7. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
Vakaloglou KM; Mavragani CP
Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
[TBL] [Abstract][Full Text] [Related]
8. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
9. Relationship of miRNA-146a to primary Sjögren's syndrome and to systemic lupus erythematosus: a meta-analysis.
Sun HY; Lv AK; Yao H
Rheumatol Int; 2017 Aug; 37(8):1311-1316. PubMed ID: 28573480
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
12. Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.
Imgenberg-Kreuz J; Almlöf JC; Leonard D; Sjöwall C; Syvänen AC; Rönnblom L; Sandling JK; Nordmark G
Front Immunol; 2019; 10():1686. PubMed ID: 31428085
[No Abstract] [Full Text] [Related]
13. Activation of the type I interferon pathway in primary Sjogren's syndrome.
Mavragani CP; Crow MK
J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
[TBL] [Abstract][Full Text] [Related]
14. Primary Sjögren's syndrome and the type I interferon system.
Nordmark G; Eloranta ML; Ronnblom L
Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
[TBL] [Abstract][Full Text] [Related]
15. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.
Reveille JD
Curr Opin Rheumatol; 1991 Oct; 3(5):722-30. PubMed ID: 1751307
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome.
Tobón GJ; Correa PA; Gomez LM; Anaya JM
Clin Exp Rheumatol; 2005; 23(3):339-44. PubMed ID: 15971421
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN signature in primary Sjögren's syndrome patients.
Brkic Z; Versnel MA
Expert Rev Clin Immunol; 2014 Apr; 10(4):457-67. PubMed ID: 24450331
[TBL] [Abstract][Full Text] [Related]
19. Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease.
Tanaka Y; Kusuda M; Yamaguchi Y
Mod Rheumatol; 2023 Aug; 33(5):857-867. PubMed ID: 36440704
[TBL] [Abstract][Full Text] [Related]
20. Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome.
Magnusson V; Nakken B; Bolstad AI; Alarcón-Riquelme ME
Scand J Immunol; 2001; 54(1-2):55-61. PubMed ID: 11439148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
